{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.1444.3.196",
  "meta": {
    "versionId": "7",
    "lastUpdated": "2021-05-21T01:00:52.000-04:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.196",
  "version": "20210521",
  "name": "Brentuximab Vedotin Injectable",
  "status": "active",
  "date": "2021-05-21T01:00:52-04:00",
  "publisher": "American Society of Clinical Oncology Steward",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "09062022",
        "concept": [
          {
            "code": "1147323",
            "display": "brentuximab vedotin 50 MG Injection"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:14c92762-7e76-4e53-9887-a247b6b3d63d",
    "timestamp": "2022-09-27T18:34:50-04:00",
    "total": 1,
    "offset": 0,
    "parameter": [
      {
        "name": "count",
        "valueInteger": 1000
      },
      {
        "name": "offset",
        "valueInteger": 0
      }
    ],
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "09062022",
        "code": "1147323",
        "display": "brentuximab vedotin 50 MG Injection"
      }
    ]
  }
}